BR112012024550A2 - processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ix - Google Patents
processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ixInfo
- Publication number
- BR112012024550A2 BR112012024550A2 BR112012024550A BR112012024550A BR112012024550A2 BR 112012024550 A2 BR112012024550 A2 BR 112012024550A2 BR 112012024550 A BR112012024550 A BR 112012024550A BR 112012024550 A BR112012024550 A BR 112012024550A BR 112012024550 A2 BR112012024550 A2 BR 112012024550A2
- Authority
- BR
- Brazil
- Prior art keywords
- vitamin
- dependent protein
- dependent
- coagulation factor
- resin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ix. processo de produção de uma proteína dependente de vitamina k livre de príons em uma sequência de purificação que emprega cromatografia caracterizado pelo fato de que - pelo menos uma etapa de cromatografia é realizada utilizando uma resina multimodal - fornecimento de uma fração que contém proteína dependente de vitamina k em uma solução aquosa; - contato da fração que contém a proteína dependente de vitamina k com uma resina multimodal em um ph entre 6-9; - opcionalmente lavagem da resina multimodal que possui a proteína dependente de vitamina k adsorvida com um tampãp de lavagem aquoso para lavar contaminantes e reter a proteína dependente de vitamina k, antes da proteína dependente de vitamina k ser eluída; - a proteína dependente de vitamina k é eluída da resina multi-modal em um ph entre 6 até 9 em um tampão que compreende arginina; e - opcionalmente coleta de frações que contêm proteína dependente de vitamina k na forma purificada ou enriquecida.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10158511.5 | 2010-03-30 | ||
| EP10158511 | 2010-03-30 | ||
| US28289510P | 2010-04-16 | 2010-04-16 | |
| US61/282,895 | 2010-04-16 | ||
| PCT/EP2011/054906 WO2011121020A1 (en) | 2010-03-30 | 2011-03-30 | A process for purifying vitamin k dependent proteins such as coagulation factor ix |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112012024550A2 true BR112012024550A2 (pt) | 2015-09-22 |
| BR112012024550B1 BR112012024550B1 (pt) | 2020-12-08 |
Family
ID=42154362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012024550-3A BR112012024550B1 (pt) | 2010-03-30 | 2011-03-30 | processo de produção de uma proteína dependente de vitamina k livre de príons em uma sequência de purificação que emprega cromatografia |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20130079498A1 (pt) |
| EP (2) | EP2553095B1 (pt) |
| JP (1) | JP5876868B2 (pt) |
| KR (1) | KR101829860B1 (pt) |
| CN (1) | CN102858971B (pt) |
| AU (2) | AU2011234521B2 (pt) |
| BR (1) | BR112012024550B1 (pt) |
| CA (1) | CA2793136C (pt) |
| DK (2) | DK2553095T3 (pt) |
| ES (2) | ES2740825T3 (pt) |
| IL (2) | IL221609A (pt) |
| MX (1) | MX2012011066A (pt) |
| RU (2) | RU2731720C2 (pt) |
| TR (1) | TR201911082T4 (pt) |
| WO (1) | WO2011121020A1 (pt) |
| ZA (1) | ZA201207227B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105777862A (zh) | 2012-10-24 | 2016-07-20 | 建新公司 | 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子 |
| CN105175486A (zh) * | 2015-10-20 | 2015-12-23 | 上海洲跃生物科技有限公司 | 一种高纯人凝血因子ix的制备方法 |
| CN105330736A (zh) * | 2015-11-06 | 2016-02-17 | 上海洲跃生物科技有限公司 | 一种从去冷胶血浆中同时制备人凝血因子ix及vii的方法 |
| CN105326859A (zh) * | 2015-11-09 | 2016-02-17 | 上海洲跃生物科技有限公司 | 一种从Cohn血浆组分III中制备人凝血酶原复合物的方法 |
| WO2018187388A1 (en) * | 2017-04-04 | 2018-10-11 | Scarab Genomics, Llc | Improved purification of crm 197 from bacteria |
| CN107460182B (zh) * | 2017-09-01 | 2020-12-18 | 上海太阳生物技术有限公司 | 一种制备活化猪血浆凝血因子x的方法 |
| CN109444422A (zh) * | 2018-12-17 | 2019-03-08 | 福建省立医院 | 一种基于upt-lf定量测定血清pivka-ii的检测卡及其构建方法及应用 |
| CN111378029B (zh) * | 2018-12-29 | 2023-05-05 | 四川远大蜀阳药业有限责任公司 | 一种人凝血因子ix的制备方法 |
| CN110257358B (zh) * | 2019-06-10 | 2023-05-19 | 广东双林生物制药有限公司 | 一种高纯人凝血因子ix制剂的生产方法 |
| CN111925450B (zh) * | 2020-09-21 | 2020-12-15 | 迈威(上海)生物科技股份有限公司 | 一种去除毕赤酵母表达重组蛋白聚集体和/或降解片段的方法 |
| CN113267390B (zh) * | 2021-05-11 | 2023-05-05 | 北京丹大生物技术有限公司 | 一种用于滤纸干血片的检测标志物洗脱液及其应用 |
| CA3233419A1 (en) * | 2021-09-28 | 2023-04-06 | Kashiv Biosciences, Llc | An improved process for purification of protein |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4540573A (en) | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
| DK162233C (da) * | 1989-11-09 | 1992-03-16 | Novo Nordisk As | Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii |
| CA2105282C (en) * | 1991-03-01 | 2002-09-24 | Centeon L.L.C. | Preparation of factor ix |
| US5286849A (en) * | 1992-07-14 | 1994-02-15 | Alpha Therapeutic Corporation | Purification of factor IX |
| DE19506633A1 (de) * | 1995-02-25 | 1996-08-29 | Octapharma Ag | Verfahren zur Herstellung von Faktor IX aus biologischen Quellen |
| US5714583A (en) * | 1995-06-07 | 1998-02-03 | Genetics Institute, Inc. | Factor IX purification methods |
| AU766551C (en) * | 1998-08-28 | 2005-02-17 | Genentech Inc. | Human anti-factor IX/IXa antibodies |
| RU2321633C2 (ru) * | 2001-02-16 | 2008-04-10 | Ново Нордиск Хелт Кэр Аг | Способ получения витамин к-зависимых белков |
| SE0203551D0 (sv) * | 2002-12-02 | 2002-12-02 | Biovitrum Ab | Prothrombin purification |
| US20040106779A1 (en) * | 2002-12-03 | 2004-06-03 | Bigler Douglas E. | Modified factor IX preparation |
| US7750129B2 (en) | 2004-02-27 | 2010-07-06 | Ge Healthcare Bio-Sciences Ab | Process for the purification of antibodies |
| AU2005252296B2 (en) | 2004-06-07 | 2009-08-20 | Evolve Biologics Inc. | Isolation of plasma or serum proteins |
| MXPA06014318A (es) * | 2004-06-07 | 2007-08-02 | Avt Plasma Ltd | Proceso para aislamiento de proteinas. |
| WO2006067230A1 (en) * | 2004-12-23 | 2006-06-29 | Novo Nordisk Health Care Ag | Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest |
| EP1707634A1 (en) * | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
| EP1739179A1 (en) | 2005-06-30 | 2007-01-03 | Octapharma AG | Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| ES2364118T3 (es) | 2007-07-11 | 2011-08-25 | Novo Nordisk A/S | Purificación de factor viii usando una resina de modo mixto o multimodal. |
| EP2027875A1 (en) | 2007-08-23 | 2009-02-25 | Octapharma AG | A Process for Isolation and Purification of a Target Protein free of Prion Protein (PrPSC) |
| ES2538706T3 (es) * | 2008-06-24 | 2015-06-23 | Octapharma Ag | Procedimiento de purificación del factor de coagulación VIII |
-
2011
- 2011-03-30 RU RU2016122883A patent/RU2731720C2/ru active
- 2011-03-30 WO PCT/EP2011/054906 patent/WO2011121020A1/en active Application Filing
- 2011-03-30 CN CN201180017406.5A patent/CN102858971B/zh not_active Expired - Fee Related
- 2011-03-30 ES ES16190737T patent/ES2740825T3/es active Active
- 2011-03-30 RU RU2012146084/10A patent/RU2590726C2/ru active
- 2011-03-30 JP JP2013501827A patent/JP5876868B2/ja not_active Expired - Fee Related
- 2011-03-30 CA CA2793136A patent/CA2793136C/en active Active
- 2011-03-30 BR BR112012024550-3A patent/BR112012024550B1/pt active IP Right Grant
- 2011-03-30 DK DK11713216.7T patent/DK2553095T3/en active
- 2011-03-30 MX MX2012011066A patent/MX2012011066A/es not_active Application Discontinuation
- 2011-03-30 DK DK16190737.3T patent/DK3133157T3/da active
- 2011-03-30 US US13/638,234 patent/US20130079498A1/en not_active Abandoned
- 2011-03-30 TR TR2019/11082T patent/TR201911082T4/tr unknown
- 2011-03-30 EP EP11713216.7A patent/EP2553095B1/en active Active
- 2011-03-30 EP EP16190737.3A patent/EP3133157B1/en active Active
- 2011-03-30 ES ES11713216.7T patent/ES2610529T3/es active Active
- 2011-03-30 AU AU2011234521A patent/AU2011234521B2/en not_active Ceased
- 2011-03-30 KR KR1020127025752A patent/KR101829860B1/ko active IP Right Grant
-
2012
- 2012-08-23 IL IL221609A patent/IL221609A/en active IP Right Grant
- 2012-09-27 ZA ZA2012/07227A patent/ZA201207227B/en unknown
-
2015
- 2015-06-19 AU AU2015203388A patent/AU2015203388B2/en active Active
-
2016
- 2016-10-27 IL IL248549A patent/IL248549B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012024550A2 (pt) | processo para purificação de proteínas dependentes de vitamina k tal como o fator de coagulação ix | |
| UA100901C2 (ru) | Способ очищения фактора свертывания крови viii | |
| BR112015023513A2 (pt) | métodos de purificação de rna | |
| AR074015A1 (es) | Purificacion de proteinas acidas utilizando cromatografia de hidroxiapatita ceramica | |
| AR086525A1 (es) | Metodo de purificacion de anticuerpos | |
| BR112017018365A2 (pt) | uso de lavagens alcalinas durante cromatografia para remoção de impurezas | |
| AR053633A1 (es) | Metodos para purificar proteinas que contienen una region fc | |
| AR062711A1 (es) | Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad | |
| BR112018008451A2 (pt) | configurações e métodos para processar gases ácidos de alta pressão sem emissões | |
| BR112016029157A2 (pt) | processo para purificar a proteína de fusão tnfr:fc | |
| BR112012024956A2 (pt) | processo para a purificação de uma proteína de fator de crescimento | |
| BR112012014791A2 (pt) | processo para a preparação de uma peneira molecular contendo cobre com a estrutura de chabazita (cha), peneira molecular contendo cobre, catalisador, uso do catalisador, sistema de tratamento de gás de escapamento, e, método para reduzir seletivamente óxidos de nitrigênio nox. | |
| EP2565206A3 (en) | Antibody purification by cation exchange chromatography | |
| BR112013028407A2 (pt) | "sequências de aminoácido direcionadas em relação aos polipeptídeos de il-17a, il-17f e/ou il17-a/f compreendendo as mesmas, seus usos, polipeptídeos, e composição farmacêutica". | |
| BR112018011567A2 (pt) | método de purificação de uma proteína de interesse, e, uso de um método. | |
| WO2015056237A3 (en) | Purification of proteins | |
| EA201691235A1 (ru) | Модифицированные серпины для лечения нарушений свертываемости крови | |
| BR112012025729A2 (pt) | purificação por adsorção de caramelo | |
| MX2016017115A (es) | Metodos y reactivos para la purificacion de proteinas. | |
| CL2016001397A1 (es) | Métodos para purificación cromatográfica de un ácido graso que comprende: una primera etapa de separación cromatográfica en fase líquida, opcionalmente, una segunda unidad para separación cromatográfica en fase líquida y opcionalmente, una tercera unidad para separación cromatográfica en fase líquida, donde, al menos, una unidad es una unidad de separación cromatográfica en lecho estático | |
| BR112014000278A2 (pt) | método para o preparo de um concentrado de imunoglobulinas polivalentes | |
| BR112015029779A8 (pt) | processo para a produção de uma quitosana alcalina com baixo teor de endotoxinas, quitina ou um derivado das mesmas; processo para a produção de uma quitosana neutra com baixo teor de endotoxinas, um sal de quitosana ou um derivado de quitosana; quitosana alcalina com baixo teor de endotoxinas, quitina, um derivado de quitosana ou um derivado de quitina; quitosana alcalina, quitina, um derivado de quitosana ou um derivado de quitina, ou uma quitosana neutra, um sal de quitosana ou um derivado de quitosana; e curativo hemostático para ferida | |
| DE502007004510D1 (de) | Halterung für eine scheinwerfereinheit, verfahren zur deren herstellung und fronteinheit | |
| AR091836A1 (es) | Metodo para purificar el factor transgenico vii | |
| BR112015008661A2 (pt) | processos de separação para proteína de soja |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/03/2011, OBSERVADAS AS CONDICOES LEGAIS. |